Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch?
Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch?
Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch?
Submitted by
admin
on November 28, 2021 - 11:03pm
Source:
Motley Fool
News Tags:
Roche
Biogen
Alzheimer's disease
Aduhelm
gantenerumab
Headline:
Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch?
snippet:
Roche could launch its Alzheimer's disease drug gantenerumab at a discount to Biogen's Aduhelm.
The Swiss pharma still needs to gain FDA approval for its drug.
Do Not Allow Advertisers to Use My Personal information